Author

Anna M. Chiarella

Columbia University Irving Medical CenterORCID 0000-0003-1224-9324Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Anil Rustgi· 1 shared Aparna Krishnan· 1 shared Benjamin IzariD· 1 shared Bret TabackiD· 1 shared Brian E. Ragaishis· 1 shared Catherine S. SpinaiD· 1 shared Chang Liu· 1 shared Chelsea L. Rahiman· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anil Rustgi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 29, 2026

Targeting CD73-A2aR-Mediated Adenosine Signaling at the Tumor-Immune Interface Overcomes Radioresistance

Shruti Bansal, Luis Aparicio, Aparna Krishnan…·Catherine S. Spina

This study shows that targeting CD73-A2aR adenosine signaling with radiotherapy and checkpoint inhibitors improves tumor control by overcoming radioresistance and enhancing antitumor immunity.

DOI 10.64898/2026.05.26.727904

mousebulk RNA-seq

𝕏 PostBluesky